MedPath

LEGACY HEALTH SYSTEM

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

29

Active:0
Completed:15

Trial Phases

4 Phases

Phase 2:7
Phase 3:1
Phase 4:3
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (26 trials with phase data)โ€ข Click on a phase to view related trials

Not Applicable
15 (57.7%)
Phase 2
7 (26.9%)
Phase 4
3 (11.5%)
Phase 3
1 (3.8%)

Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia

Not Applicable
Terminated
Conditions
Covid19
First Posted Date
2020-11-06
Last Posted Date
2023-03-09
Lead Sponsor
Legacy Health System
Target Recruit Count
27
Registration Number
NCT04619719
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Bozeman Health, Bozeman, Montana, United States

๐Ÿ‡บ๐Ÿ‡ธ

NYU Winthrop Hospital, Mineola, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Legacy Emanuel Medical Center, Portland, Oregon, United States

Supracondylar Pinning Antibiotic Stewardship (SPAS) Trial

Not Applicable
Conditions
Infection
Supracondylar Humerus Fracture
Interventions
Drug: normal saline
First Posted Date
2020-02-28
Last Posted Date
2022-04-12
Lead Sponsor
Legacy Health System
Target Recruit Count
1200
Registration Number
NCT04288206
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Legacy Emanuel Medical Center, Portland, Oregon, United States

Effects of HBO on Glucose in Patients With DM

Not Applicable
Suspended
Conditions
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
First Posted Date
2020-02-10
Last Posted Date
2024-05-16
Lead Sponsor
Legacy Health System
Target Recruit Count
24
Registration Number
NCT04261738
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Legacy Emanuel Medical Center, Portland, Oregon, United States

Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation

Phase 4
Conditions
Extracorporeal Membrane Oxygenation Complication
Anticoagulants
Interventions
First Posted Date
2019-05-28
Last Posted Date
2019-05-28
Lead Sponsor
Legacy Health System
Target Recruit Count
34
Registration Number
NCT03965208
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Legacy Health System, Portland, Oregon, United States

Acute Post-Radiation Hyperbaric Oxygen (HBO2) for Breast Cancer Patients Who Have Recently Completed Radiation Therapy

Phase 2
Terminated
Conditions
Breast Cancer
Interventions
Procedure: Hyperbaric Oxygen Therapy
Dietary Supplement: Vitamin E
First Posted Date
2019-04-16
Last Posted Date
2023-10-04
Lead Sponsor
Legacy Health System
Target Recruit Count
1
Registration Number
NCT03916068
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Legacy Emanuel Medical Center, Portland, Oregon, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.